Hypersensitivity reaction and tolerance induction to ethambutol.

Area of Science:

• Infectious Diseases
• Pharmacology
• Clinical Medicine

Background:

• Tuberculosis (TB) is a leading global infectious cause of death, with increasing incidence.
• Mycobacterium infections often require multi-drug therapy.
• Adverse reactions to anti-TB drugs affect approximately 5% of patients, potentially leading to treatment cessation or modification.

Purpose of the Study:

• To describe a case of Mycobacterium avium complex (MAC) infection.
• To present a modified desensitization protocol for ethambutol, a critical drug for MAC treatment.
• To address challenges in managing adverse drug reactions during multi-drug TB therapy.

Main Methods:

• Diagnosis of drug-induced reactions typically involves drug withdrawal and sequential reintroduction.
• Desensitization procedures are considered when alternative effective drugs are unavailable.
• A modified desensitization protocol for ethambutol was developed and applied.

Main Results:

• The patient had a Mycobacterium avium complex infection requiring ethambutol treatment.
• Adverse reactions to ethambutol necessitated a desensitization procedure.
• The modified desensitization protocol facilitated the successful administration of ethambutol.

Conclusions:

• Managing adverse reactions to essential anti-tuberculosis drugs is clinically significant.
• Desensitization protocols, like the modified ethambutol protocol presented, can be vital for treatment adherence and efficacy.
• This case highlights a potential strategy for managing ethambutol hypersensitivity in MAC infections.